Faculty

Institution

Unit

Venue

Michael Cleary

Lindhard Family Professor of Pediatric Cancer Biology and Professor of Pathology Emeritus

Stanford University

Affiliations

School of Medicine

Dermatology

Pathology

Experimental Pathology

Dermatology

Program in Epithelial Biology

Michael Cleary is currently serving as a Dermatology Lindhard Family Professor of Pediatric Cancer Biology and Professor of Pathology Emeritus at Stanford University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Michael Cleary

Stanford University

Lindhard Family Professor of Pediatric Cancer Biology and Professor of Pathology Emeritus

You can click a keyword to filter the displayed items

genetics hematology molecular biology cell biology immunology oncology gene expression cancer genetics cancer biology cancer research tumor biology leukemia oncogenes mammalian biology hematological malignancies medicinal research lymphoid neoplasia cytogenetics protein science molecular cancer genomics structural biology molecular and cellular biology molecular cell biology cancer genomics genome biology cancer cells stem cell research gene function chromosome biology transcription regulation cancer care cell regulation cellular therapy protein expression cellular biology gene regulation avian biology experimental medicine rna biology oncogenic agent medical genetics animal genetics epigenetic changes blood cells chromosomal translocation developmental science cancer treatment clinical pathology molecular regulation chromosomal translocations bone marrow transplantation developmental genetics viral oncology human pathology hemostasis acute leukemias myeloid progenitors protein function follicular lymphoma leukemia stem cells tumor targeting cancer growth protein genetics disease detection gene structure breakpoint cluster region human follicular lymphomas acute leukemia leukemia proto-oncoprotein mll b-cell lymphoma molecular analysis malignant lymphomas mll oncoproteins situ hybridization clonal rearrangements

Notable Scholarly Works

Notable Federal Grants

Collaborators

Structure-Function Relationship of Ash1L and Histone H3K36 and H3K4 Methylation. Nature Communications (2025)

Kendra R. VannRajal SharmaChih-Chao HsuMaeva DevoucouxAdam H. TencerLei ZengKevin LinLi ZhuQin LiCatherine LachanceRuben Rosas OspinaQiong TongKa Lung CheungShuai YangSoumi BiswasHongwen XuanJovylyn GatchalianLorena AlamilloJianlong WangSuk Min JangBrianna J. KleinYue LuPatricia ErnstBrian D. StrahlScott B. RothbartMartin J. WalshMichael L. ClearyJacques CôtéXiaobing ShiMing-Ming ZhouTatiana G. Kutateladze

geneticsstructure-function relationshipchromatinmolecular structurebiomolecular structureprotein structurebiochemistrymolecular biologyepigenetic changesstructural biology

Development of Combination Therapies With Btk Inhibitors and Dasatinib to Treat Cns-Infiltrating E2A-Pbx1+/Prebcr+ All. Blood Advances (2024)

Gaia GentileTeresa PoggioAntonella CatalanoMinna VoutilainenMari LahnalampiMarta Andrade-MartinezTobias MaRoman SankowskiLina GoncharenkoStefan TholenKyuho HanDavid W. MorgensMarco PrinzMichael LübbertSophia EngelTanja Nicole HartmannGunnar CarioMartin SchrappeLennart LenkMartin StanullaJustus DuysterPeter BronsertMichael C. BassikMichael L. ClearyOliver SchillingMerja HeinäniemiJesús Duque-Afonso

hematologymedicineoncologybtk inhibitorspharmacologycombination therapiesdrug discoverypharmacotherapytreatment development

Early-Life Infection Depletes Preleukemic Cells in a Mouse Model of Hyperdiploid B-Cell Acute Lymphoblastic Leukemia. Blood (2024)

Ali FarrokhiTanmaya AtreSamuel SalitraMaryam AletahaAna Citlali MárquezMatthew GynnMario FidanzaSumin JoNina RolfKaren SimmonsJesus Duque-AfonsoMichael L. ClearyAlix E. SeifTobias KollmannSoren GanttGregor S. D. Reid

hematologymedicineoncologyhematological malignanciesinfectious diseasescancer biologylymphoid neoplasiaimmunologymouse model

Age and Ligand Specificity Influence the Outcome of Pathogen Engagement on Preleukemic and Leukemic B-Cell Precursor Populations. Blood Advances (2023)

Tanmaya AtreAli FarrokhiSumin JoSamuel SalitraJesus Duque-AfonsoMichael L. ClearyNina RolfGregor S. D. Reid

ligand specificity influencecancer immunotherapyleukemiaageingpharmacologycellular therapyclinical microbiologyinnate immune systemlaboratory medicinepathogen engagementimmunologymedicinal researchhematologyhemostasisinflammationaging-associated diseaseshematological malignanciesdermatologyregenerative medicinehost specificity

Data From Ash1L Links Histone H3 Lysine 36 Dimethylation to Mll Leukemia. (2023)

Li ZhuQin LiStephen H.K. WongMin HuangBrianna J. KleinJinfeng ShenLarissa IkenouyeMasayuki OnishiDominik SchneidawindCorina BuecheleLoren HansenJesús Duque-AfonsoFangfang ZhuGloria Mas MartinOr GozaniRavindra MajetiTatiana G. KutateladzeMichael L. Cleary

epigeneticsgeneticschromatincell biologyleukemiagenomicsepigenomicsmammalian biologymolecular biologycancer genetics

Data From Cbp Modulates Sensitivity to Dasatinib in Pre-Bcr Sup + /Sup Acute Lymphoblastic Leukemia. (2023)

Jesús Duque-AfonsoChiou-Hong LinKyuho HanDavid W. MorgensEdwin E. JengZiming WengJohan JeongStephen Hon Kit WongLi ZhuMichael C. WeiHee-Don ChaeMartin SchrappeGunnar CarioJustus DuysterXiangshu XiaoKathleen M. SakamotoMichael C. BassikMichael L. Cleary

hematologycancer immunotherapygeneticsepigeneticscancer biologycytogeneticsimmunotherapylymphoid neoplasiaimmunologypharmacologylymphoblastic leukemiacancer geneticshost specificitycbp modulates sensitivity

Data From E2A-Pbx1 Remodels Oncogenic Signaling Networks in B-Cell Precursor Acute Lymphoid Leukemia. (2023)

Jesús Duque-AfonsoChiou-Hong LinKyuho HanMichael C. WeiJue FengJason H. KurzerCorina SchneidawindStephen Hon-Kit WongMichael C. BassikMichael L. Cleary

cancer immunotherapygeneticssignaling pathwayscancer biologygene regulatory networksdermatologycell signalingoncogenic agentlymphoid neoplasiaimmunologymedicinal research

Enhancer Remodeling Drives Mll Oncogene-Dependent Transcriptional Dysregulation in Leukemia Stem Cells. Blood Advances (2023)

Feng PanMasayuki IwasakiWenqi WuYanan JiangXin YangLi ZhuZhigang ZhaoMichael L. Cleary

medicinecell biologyleukemiagene expressiontumor biologystem cell researchblood cellscell regulationgeneticsmedicinal researchleukemia stem cellshematologystem cellsgene regulationoncogene-dependent transcriptional dysregulationoncogenesregenerative medicinetranscription regulationexperimental medicinecancer genetics

Functional Characterization of Transforming Growth Factor-β Signaling in Dasatinib Resistance and Pre-Bcr+ Acute Lymphoblastic Leukemia. Cancers (2023)

Gila Mostufi-Zadeh-HaghighiPia VerattiKyra ZodelGabriele GreveMiguel WaterhouseRobert ZeiserMichael L. ClearyMichael LübbertJesús Duque-Afonso

cancer immunotherapycancer biologycell signalingleukemiapharmacologygrowth factor-b signalingtumor biologycellular therapyfunctional characterizationcancer researchoncologycancer carecancer genomicsmolecular cancerdasatinib resistancelymphoid neoplasiaimmunologymedicinal researchhematological malignanciesmolecular biologycancer genetics

Genome Editing–Induced T(4;11) Chromosomal Translocations Model B Cell Precursor Acute Lymphoblastic Leukemias With Kmt2A-Aff1 Fusion. Journal of Clinical Investigation (2023)

Feng PanJolanda SarnoJohan JeongXin YangAstraea JagerTanja A. GruberKara L. DavisMichael L. Cleary

clinical investigationcancer genomicsgeneticstranslational medicinecancer researchcancer biologyleukemiacytogeneticsgenomicsimmunologylymphoid neoplasiagenome biologymolecular biologyclinical researchcancer geneticsgenome editing

1
2
3
4
5
26
10 / page

Michael Cleary

Lindhard Family Professor of Pediatric Cancer Biology and Professor of Pathology Emeritus

Stanford University

Affiliations

School of Medicine

Dermatology

Pathology

Experimental Pathology

Dermatology

Program in Epithelial Biology

Michael Cleary is currently serving as a Dermatology Lindhard Family Professor of Pediatric Cancer Biology and Professor of Pathology Emeritus at Stanford University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Michael Cleary

Stanford University

Lindhard Family Professor of Pediatric Cancer Biology and Professor of Pathology Emeritus

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Structure-Function Relationship of Ash1L and Histone H3K36 and H3K4 Methylation. Nature Communications (2025)

geneticsstructure-function relationshipchromatinmolecular structurebiomolecular structureprotein structurebiochemistrymolecular biologyepigenetic changesstructural biology

Development of Combination Therapies With Btk Inhibitors and Dasatinib to Treat Cns-Infiltrating E2A-Pbx1+/Prebcr+ All. Blood Advances (2024)

hematologymedicineoncologybtk inhibitorspharmacologycombination therapiesdrug discoverypharmacotherapytreatment development

Early-Life Infection Depletes Preleukemic Cells in a Mouse Model of Hyperdiploid B-Cell Acute Lymphoblastic Leukemia. Blood (2024)

hematologymedicineoncologyhematological malignanciesinfectious diseasescancer biologylymphoid neoplasiaimmunologymouse model

Age and Ligand Specificity Influence the Outcome of Pathogen Engagement on Preleukemic and Leukemic B-Cell Precursor Populations. Blood Advances (2023)

Tanmaya AtreAli FarrokhiSumin JoSamuel SalitraJesus Duque-AfonsoMichael L. ClearyNina RolfGregor S. D. Reid

Data From Ash1L Links Histone H3 Lysine 36 Dimethylation to Mll Leukemia. (2023)

epigeneticsgeneticschromatincell biologyleukemiagenomicsepigenomicsmammalian biologymolecular biologycancer genetics

Data From Cbp Modulates Sensitivity to Dasatinib in Pre-Bcr Sup + /Sup Acute Lymphoblastic Leukemia. (2023)

Data From E2A-Pbx1 Remodels Oncogenic Signaling Networks in B-Cell Precursor Acute Lymphoid Leukemia. (2023)

Jesús Duque-AfonsoChiou-Hong LinKyuho HanMichael C. WeiJue FengJason H. KurzerCorina SchneidawindStephen Hon-Kit WongMichael C. BassikMichael L. Cleary

cancer immunotherapygeneticssignaling pathwayscancer biologygene regulatory networksdermatologycell signalingoncogenic agentlymphoid neoplasiaimmunologymedicinal research

Enhancer Remodeling Drives Mll Oncogene-Dependent Transcriptional Dysregulation in Leukemia Stem Cells. Blood Advances (2023)

Feng PanMasayuki IwasakiWenqi WuYanan JiangXin YangLi ZhuZhigang ZhaoMichael L. Cleary

Functional Characterization of Transforming Growth Factor-β Signaling in Dasatinib Resistance and Pre-Bcr+ Acute Lymphoblastic Leukemia. Cancers (2023)

Gila Mostufi-Zadeh-HaghighiPia VerattiKyra ZodelGabriele GreveMiguel WaterhouseRobert ZeiserMichael L. ClearyMichael LübbertJesús Duque-Afonso

Genome Editing–Induced T(4;11) Chromosomal Translocations Model B Cell Precursor Acute Lymphoblastic Leukemias With Kmt2A-Aff1 Fusion. Journal of Clinical Investigation (2023)

Feng PanJolanda SarnoJohan JeongXin YangAstraea JagerTanja A. GruberKara L. DavisMichael L. Cleary

1
2
3
4
5
26
10 / page

Similar Faculty Members

Charles Eberhart

Institution

Johns Hopkins University

oncology

neurology

Jonathan D Licht

Institution

University of Florida

oncology

pathology

Stephen D. Nimer

Institution

University of Miami

molecular biology

haematopoiesis

Robert J. Coffey, M.D

Institution

Vanderbilt University

gi neoplasia

oncogene

M. Simon

Institution

University of Pennsylvania

free radical biology

biological microenvironments

Dana Borden Lacy

Institution

Vanderbilt University

pathogen

infectious diseases

Michelle M. Lebeau

Institution

University of Chicago

genetics

hematology

Scott W. Hiebert

Institution

Vanderbilt University

nascent transcription

oncogene

Michael P. Snyder

Institution

Stanford University

genetics

molecular biology

Samuel French

Institution

University of California, Los Angeles

hepatology

pharmacology

Similar Faculty Members

Charles Eberhart

Institution

Johns Hopkins University

oncology

neurology

Jonathan D Licht

Institution

University of Florida

oncology

pathology

Stephen D. Nimer

Institution

University of Miami

molecular biology

haematopoiesis

Robert J. Coffey, M.D

Institution

Vanderbilt University

gi neoplasia

oncogene

M. Simon

Institution

University of Pennsylvania

free radical biology

biological microenvironments

Dana Borden Lacy

Institution

Vanderbilt University

pathogen

infectious diseases

Michelle M. Lebeau

Institution

University of Chicago

genetics

hematology

Scott W. Hiebert

Institution

Vanderbilt University

nascent transcription

oncogene

Michael P. Snyder

Institution

Stanford University

genetics

molecular biology

Samuel French

Institution

University of California, Los Angeles

hepatology

pharmacology